COVID-19 treatment, developed from tiny llama antibodies, could potentially be the future of administering vaccines and protecting against infectious diseases, according to some experts.Researchers at the Rosalind Franklin Institute in the U.K.
have found that nanobodies, a smaller form of antibody developed by llamas and camels, could effectively target the virus that causes COVID-19 infections.In a statement, researchers at the institute said that they were able to create nanobodies by injecting a part of the SARS-CoV-2 spike protein into a llama called Fifi.